UK Will Temporarily Pause J&J Vaccines; Continue Administering Pfizer
LEXINGTON, Ky. (April 13, 2021) — In an abundance of caution, the University of Kentucky will temporarily pause administering the Johnson & Johnson (J&J) vaccine at the Gatton Student Center site following recommendations this morning by the federal government.
Vaccines will continue to be administered to those who are scheduled for appointments using the Pfizer two-shot vaccine until further guidance is issued by the federal government about J&J.
The federal government made the recommendations early this morning after reports that six recipients of the J&J vaccine in other locations in the United States – out of some 6.8 million doses delivered -- developed blood clots within about two weeks of receiving the J&J vaccine.
The federal government paused administering the J&J vaccine at its vaccination sites and recommended that state locations do the same.
UK is following that recommendation while further study around the vaccine is conducted.
UK’s other vaccine sites – at Kroger Field, University Health Service, its retail pharmacy and mobile clinic sites – already utilize either the Pfizer or Moderna vaccines.
As more information becomes available, UK and health officials will move quickly to communicate the latest details, acting always in the best interests of the health and safety of the community.
Go to https://www.uky.edu/coronavirus/vaccines for the latest information. You may also call 859-218-0111 (UK Health Corps) if you have questions.
LEXINGTON, Ky. (April 12, 2021) — The Johnson & Johnson (J&J) vaccine is still available to UK students at the Wild Health testing location in the Blue Box Theater at the Gatton Student Center.
The one-shot J&J vaccine was available at two locations during the week of April 5. Moving forward, the vaccine will be available at one location — the Gatton Student Center — for extended hours: from 9 a.m.-5 p.m. Tuesday-Sunday.
Appointments are preferred but not required. Registering only takes a few minutes.
- Students who already plan on getting a COVID-19 test, are encouraged to consider receiving a J&J vaccine while they are there and upon completing their test.
- Students should bring their student ID.
- Those who have signed up to be vaccinated at Kroger Field but would prefer the J&J vaccine instead, should cancel their Kroger Field appointment. They can do that here and use their unique access code that was sent to the email used in the vaccine request form.
- The J&J vaccine will be available while supplies last.
- Individuals must be 18 or older to receive the J&J vaccine. Those 16 or 17 years of age can go to Kroger Field but must be accompanied by a parent or legal guardian.
MORE ABOUT THE J&J VACCINE:
- The J&J vaccine is the third of three vaccines being widely administered throughout the United States. As with the other two vaccines — produced by Pfizer and Moderna — J&J's vaccine was the subject of multiple clinical trials involving thousands of people and was subject to extensive review and scrutiny before being approved by the U.S. Federal Drug Administration.
- It is safe and highly effective in preventing the virus and serious illness.
- More specifically, it was 85 percent effective at protecting against severe cases of illness in late-stage trials, and no deaths or hospitalizations occurred a month after participants received the vaccine.
- You can read more information and view some videos about the J&J vaccine here.
THE KROGER FIELD VACCINE CLINIC:
- The Kroger Field Vaccine Clinic continues to be operational. If you would prefer to receive your vaccination (currently administering Pfizer vaccine) at this location, you can register here.
- If you have already registered and want to keep your appointment, you do not need to change anything. Please plan on coming to Kroger Field at your scheduled time.
If individuals have any questions, they can contact our team at firstname.lastname@example.org or 859-218-0111. You can also visit our student vaccine webpage for more information and answers to frequently asked questions.
The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion four years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for" three years in a row, and UK is among only 22 universities in the country on Forbes' list of "America's Best Employers." We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for five straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.